- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02126566
Multiclear Treatment for Striae Distensae - A Pilot Study
Phase 2 Study of Multiclear Treatment for Striae Distensae - A Pilot Study
Striae distensae is a common skin condition that rarely causes significant medical problems. However, it often results in a considerable amount of distress to those with the condition. Various modalities of treatments have been used for striae distensae but few have led to satisfactory results.
More recently, newer techniques such as pulsed dye laser and radiofrequency devices have been used with modest results. There is still, however, paucity of data using light therapy for the treatment of this condition. Blue light therapy using the Multiclear device has been used successfully in the treatment of acne. In contrast, there is little data to suggest its use in the management of striae distensae.
We aim to study the effects of blue light on the treatment of striae distensae and whether this can be used safely to manage this condition.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients will receive twice weekly blue light treatment with the Multiclear device. The first treatment dose will be 75mJ/cm2 ( Minimum Effective Dose;MED) for all patients. If no erythema develops, the subsequent treatment dose can be increased by 0.5 MED. If mild to moderate erythema develops, the same dose (i.e. 1 MED) will be used.If severe erythema/ blisters develop, treatment will be stopped and the patient wil be invited one week later and treatment will be offered at 50% of the last dose.
During the first consultation, patients will be assessed for the presence of striae distensae (SD). Duration and previous treatments of SD will be recorded. The width of the widest striae and the length of the longest straie will be measured at baseline and after 2 months of treatment. Photographs will be taken at baseline and post treatment. These will be evaluated by dermatologists who will be blinded (i.e. details of which photographs are pre or post treatment will not be given). Subjective scores will be used (Very good to excellent; >75%, Good; 51-75%, Moderate; 26-50%, Minimal to no improvement; <25%) Participants will also be given a feedback form to rate any improvements noted and any side effects experienced.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 119074
- National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Both male and female subjects
- Patients above 21 years
- Patients who are able to attend follow up regularly
Exclusion Criteria:
- Patients with other co-existing dermatoses
- Patients with epilepsy/ who are pregnant
- Patients with previous intolerable treatment to blue light
- Patients treated with blue light within the last six months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single Arm
Administration of light therapy - measurement of results before and after therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in Striae
Time Frame: 2 months
|
The width of the widest striae and the length of the longest straie will be measured at baseline and after 2 months of treatment. Photographs will be taken at baseline and post treatment. These will be evaluated by dermatologists who will be blinded (i.e. details of which photographs are pre or post treatment will not be given). Subjective scores will be used (Very good to excellent; >75%, Good; 51-75%, Moderate; 26-50%, Minimal to no improvement; <25%) Participants will also be given a feedback form to rate any improvements noted and any side effects experienced. |
2 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013/00518
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Striae Distensae
-
First Affiliated Hospital of Jinan UniversityScience and Technology Program of Guangzhou,Guangzhou Sipintang Biological...UnknownTreatments of Striae DistensaeChina
-
Kasr El Aini HospitalCompleted
-
First Affiliated Hospital of Jinan UniversityScience and Technology Program of GuangzhouUnknownTreatments of Striae GravidarumChina
-
Jose R. Reyes Memorial Medical CenterCompletedStriae GravidarumPhilippines
-
Shahid Beheshti University of Medical SciencesCompletedExcimer Laser | White StriaeIran, Islamic Republic of
-
Al-Azhar UniversityRecruiting
-
American University of Beirut Medical CenterWellcome TrustCompleted
-
Brazilan Center for Studies in DermatologyCompletedTreatment | Striae | Stretch MarksBrazil
-
Candela FranceCompleted
-
Mahidol UniversityUnknown
Clinical Trials on Administration of light therapy - measurement of results before and after therapy
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingBladder Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Genitourinary System NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedAcute Leukemia | Refractory Leukemia | Recurrent LeukemiaUnited States
-
University of Roma La SapienzaAUSL LatinaNot yet recruitingCognitive Impairment | Normal Pressure HydrocephalusItaly
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage III Prostate Cancer AJCC v8 | Advanced Prostate CarcinomaUnited States
-
Craig L Slingluff, JrRecruiting
-
Czech Technical University in PragueRecruitingBlood Pressure | Heart RateCzechia
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)CompletedTreatment of Depressive Symptoms in Cancer PatientsCanada
-
Ottawa Hospital Research InstituteCompleted
-
Beijing Airdoc Technology Co., Ltd.CompletedMyopia | Amblyopia | Ametropia | Refractive Error - Myopia AxialChina
-
Centre Hospitalier Annecy GenevoisCompletedSleep Disorder | Hemodialysis | Chronic Renal Failure | Light TherapyFrance